Search
Search Results
##search.searchResults.foundPlural##
-
CMV IN HEMATOPOIETIC STEM CELL TRANSPLANTATION
4739PDF: 1740HTML: 2693Untitled: 207 -
FAMILIAL MEDITERRANEAN FEVER AND HYPERCOAGULABILITY
1178PDF: 702HTML: 1221 -
“IDENTIFYING HIGH-RISK CHRONIC LYMPHOCYTIC LEUKEMIA: A PATHOGENESIS-ORIENTED APPRAISAL OF PROGNOSTIC AND PREDICTIVE FACTORS IN PATIENTS TREATED WITH CHEMOTHERAPY WITH OR WITHOUT IMMUNOTHERAPY.”
3975PDF: 1032HTML: 3572Untitled: 171Cneo. Fig.1: 107Untitled: 97Untitled: 122Untitled: 125 -
SICKLE CELL ANAEMIA AND MALARIA
11308PDF: 6935HTML: 23811Figures Malaria and SCK: 201 -
THE EFFECT OF ALPHA THALASSEMIA, HBF and HBC ON HAEMATOLOGICAL PARAMETERS OF SICKLE CELL DISEASE PATIENTS IN IBADAN, NIGERIA. ALPHA THALASSEMIA, HBF and HBC ON HAEMATOLOGICAL PARAMETERS OF SICKLE CELL DISEASE PATIENTS
2231PDF: 957HTML: 63 -
PREVALENCE OF SERIOUS BACTERIAL INFECTIONS IN CHILDREN WITH SICKLE CELL DISEASE AT KING ABDULAZIZ HOSPITAL, AL AHSA Bacterial infections in children with sickle cell diseas
1494PDF: 565HTML: 208 -
CLINICAL ASPECTS OF UNCOMPLICATED AND SEVERE MALARIA
7804PDF: 4062HTML: 7321 -
Spontaneous rupture of malarial spleen: report of two cases
776PDF: 401HTML: 2860jdoe, cover letter.doc: 172 -
-
WHAT UNRELATED HEMATOPOIETIC STEM CELL TRANSPLANTATION IN THALASSEMIA TAUGHT US ABOUT TRANSPLANT IMMUNOGENETICS.
3121PDF: 1122HTML: 1470Untitled: 168Untitled: 159Untitled: 161 -
EPIDEMIOLOGY OF THERAPY-RELATED MYELOID NEOPLASMS IN THE NORDIC COUNTRIES
2162PDF: 790HTML: 1616Figure 1: 174Table 1: 196 -
TREATMENT OF INDOLENT AND ADVANCED SYSTEMIC MASTOCYTOSIS Systemic Mastocytosis Treatment
2036PDF: 1493HTML: 264 -
PEDIATRIC MASTOCYTOSIS: AN UPDATE Chldren' Mastocytosis
1806HTML: 1408PDF: 1063 -
A MULTICENTER EXPERIENCE FROM LEBANON IN CHILDHOOD AND ADOLESCENT ACUTE MYELOID LEUKEMIA:HIGH RATE OF EARLY DEATH IN CHILDHOOD ACUTE PROMYELOCYTIC LEUKEMIA.
2042PDF: 1105HTML: 7681cover letter paper final AML: 210 -
IMPACT OF COVID-19 ON OUTCOMES OF PATIENTS WITH HEMATOLOGIC MALIGNANCIES: A MULTI-CENTER, RETROSPECTIVE STUDY COVID-19 and hematologic malignancy
1431PDF: 753HTML: 194 -
GENETIC PATHWAYS LEADING TO THERAPY-RELATED MYELOID NEOPLASMS
2547PDF: 793HTML: 5199 -
IDENTİFİCATİON OF LEİSHMANİA TROPİCA FROM PEDİATRİC VİSCERAL LEİSHMANİASİS İN SOUTHERN MEDITERRANEAN REGION OF TURKEY. Molecular characterization of pediatric visceral leishmaniasis
962PDF: 686HTML: 215 -
THE SPECTRUM OF GENETIC DEFECTS IN CHRONIC LYMPHOCYTIC LEUKEMIA
2207PDF: 870HTML: 1989Fig 1 Rossi: 170 -
-
LIMITED STAGE FOLLICULAR LYMPHOMA: THE ROLE OF RADIATION THERAPY.
3671PDF: 1074HTML: 2272Figure 1: 205 -
PATHOGENESIS OF MALARIA IN TISSUES AND BLOOD
4410PDF: 1904HTML: 17716 -
Acute Cytomegalovirus infection as a cause of venous thromboembolism
1548PDF: 837HTML: 1026Picture 1: 161 -
SHORT HISTORY OF MALARIA AND ITS ERADICATION IN ITALY
4692PDF: 1867HTML: 11025Fig 1: 216Fig 2: 175Fig 3: 295Fig 4: 181Fig 5: 172Fig 6: 169Fig 7: 181Fig 8: 174 -
DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES: ANALOGIES AND DIFFERENCES DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES
1339HTML: 379PDF: 808 -
-
ROLE OF HEMATOPOIETIC STEM CELL TRANSPLANTATION
1989PDF: 785HTML: 1031 -
ASSESSMENT OF THE EFFICACY OF PROCALCITONIN, C-REACTIVE PROTEIN AND ALBUMIN LEVELS-GUIDED ANTIBIOTICS USE IN SEPSIS
891PDF: 478Html: 135Suppl. Files: 166 -
PROPHYLAXIS OF MALARIA
2973PDF: 1008HTML: 17783Figures SChwartz: 157 -
PRACTICAL RECOMMENDATIONS FOR THE MANAGEMENT OF PATIENTS WITH ITP DURING THE COVID-19 PANDEMIC Recommendation for ITP management during COVID
2404PDF: 907HTML: 505 -
CHRONIC MYELOPROLIFERATIVE NEOPLASMS: A COLLABORATIVE APPROACH
1641PDF: 711HTML: 2329 -
The diagnostic pitfalls of mucormycosis
872PDF: 704HTML: 236 -
NUTRITIONALLY VARIANT STREPTOCOCCI BACTEREMIA IN CANCER PATIENTS: A RETROSPECTIVE STUDY, 1999-2014
2057PDF: 981HTML: 4058Cover Letter: 216Figure 1: 223Figure 2: 225Table 1: 200 -







